RNAC
Cartesian Therapeutics, Inc. · Healthcare
CTO Metin Kurtoglu sold $649K of Cartesian Therapeutics, Inc.
Sold$649,030
$16.78Price
38,689Shares
−43%Stake
What RNAC did after the filing
- The stock from Thu, Nov 21 close, $16.62
- +3.2%
- S&P 500, same days
- −0.5%
Measured over 30 trading days, to the Jan 7 close.
Traded Tue, Nov 19. Filed Thu, Nov 21, 1:52 PM ET, during the session. Returns use the Nov 21 close and the Jan 7 close. Not investment advice.